Matt Plevelich

Matt Plevelich is a Principal at NewSpring Capital, specifically working with the firm's dedicated healthcare strategy called NewSpring Healthcare.12 He joined NewSpring in 2008 and has over 14 years of experience in the private equity industry, focusing on healthcare investments.2

Career Highlights

NewSpring Capital:

• Joined the firm in 2008, starting as an intern and rising through the ranks to become a Principal3
• Specializes in sourcing, underwriting, and executing new investments, as well as monitoring existing investments in the healthcare sector12
• Serves on the boards of NewSpring portfolio companies, including Verisma and BRC Healthcare2
• Acts as an observer for ContinuumRx and SUN Behavioral2

Recent Transition: As of September 2024, Matt Plevelich has taken on a new role as SVP of Corporate Development at Verisma, a leading provider of health information solutions.3 This move indicates his transition from private equity to a more operational role in the healthcare technology sector.

Education and Early Career

• Received a BBA with a concentration in Finance from The George Washington University12
• While completing his degree, he interned at Ferris Baker Watts, Washington D.C.'s largest full-service investment bank at the time, where he conducted in-depth research for high-net-worth clients12

Additional Involvement

Matt Plevelich also serves on the Board of Gaudenzia, the largest nonprofit provider of substance use disorder (SUD) treatment in the Mid-Atlantic region.35

Matt Plevelich's LinkedIn profile can be found under the username matt-plevelich-3914bba, which confirms his professional background and current position.4